Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620254 · ClinicalTrials.gov registry record
Mast Cell Connect: A Registry for Patients With Mastocytosis
A clinical trial, sponsored by Blueprint Medicines Corporation.
- Completed
- Registry status
- 743
- Enrollment target
NCT02620254 is a clinical trial that has completed, run by Blueprint Medicines Corporation. The registered enrollment target is 743 participants.
The verdict
NCT02620254 has completed, sponsored by Blueprint Medicines Corporation.
- COMPLETED
- Registry status
- 743 participants
- Enrollment target
Study Summary
The Mast Cell Connect Registry is a voluntary, observational database that will capture demographic, socioeconomic, and disease information directly from patients with mastocytosis via a secure web-based tool. No experimental intervention is involved.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 743 participants |
| Start Date | 2015-11 |
| Est. Completion | 2021-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620254
The ClinicalTrials.gov registry entry for NCT02620254 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 743 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Blueprint Medicines Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02620254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620254 about?
NCT02620254 is a clinical study titled "Mast Cell Connect: A Registry for Patients With Mastocytosis". The Mast Cell Connect Registry is a voluntary, observational database that will capture demographic, socioeconomic, and disease information directly from patients with mastocytosis via a secure web-based tool. No experimental intervention is involved.
What is the current status of trial NCT02620254?
This trial is currently completed. The enrollment target is 743 participants. The study started on 2015-11. Estimated completion is 2021-01.
Who is sponsoring clinical trial NCT02620254?
This trial is sponsored by Blueprint Medicines Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.